Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4201 AL 4215

Polyamine metabolic enzyme SAT1 remodels the neuronal transcriptome and rescues α-synuclein toxicity in Drosophila

Bangash ZR, Matsui H, Ranxhi B, Todi SV, LeWitt PA, Tsou WL.

Res Sq [Preprint]. 2026 Feb 16:rs.3.rs-8780765. doi: 10.21203/rs.3.rs-8780765/v1.

Deep brain stimulation for Parkinson's disease in India: an expert consensus on availability, affordability, and eligibility by the Parkinson's research alliance India (PRAI)

Metta V, Mridula R, Hosurkar G, Wadia P, Sankhla C, Agarwal P, Gurram S, Garg D, Mehta S, Kumar H, Ganguly J, Rajan R, Elavarasi A, Desai S, Sahoo LK, Shankar V, Joshi D, Krishnan S, Kola S, Barad N, Holla V, Chacko J, Kumar S, Kishore A, Kukkle PL, Alogolu R, Goyal V, Dhamija KR, Chaudhuri KR, Borgohain R.

J Neural Transm (Vienna). 2026 Feb 3. doi: 10.1007/s00702-026-03106-2. Online ahead of print.

Brazilian version of the Fear of Falls Scale: translation, cross-cultural adaptation and validation

Amaral CMSD, Gomes ABF, Surerus RBM, Lacerda PPS, Oliveira VF, Scott SSO, de Almeida SB, Santos WSD, Vale TC, Carvalho FMM, Braga-Neto P.

Arq Neuropsiquiatr. 2026 Jan;84(1):1-7. doi: 10.1055/s-0045-1815738. Epub 2026 Feb 4.

Effect of the online Rethink My Drink alcohol intervention on alcohol use and cognition in older adults in Australia: a randomised controlled trial

Mewton L, Winter V, Hoy N, Visontay R, Davies S, Kochan N, Baillie A, Chapman C, Newton NC, Sunderland M, Sachdev PS, Teesson M.

Lancet Public Health. 2026 May;11(5):e318-e328. doi: 10.1016/S2468-2667(26)00056-3.

Budget impact analysis of deep brain stimulation devices with different longevity in Parkinson's disease: insights from real-world data

Sensi M, Antenucci P, Colucci F, Gozzi A, Capone JG, Angelini C, Waheed F, Cavallo MA, Scerrati A.

Front Public Health. 2026 Jan 23;14:1735033. doi: 10.3389/fpubh.2026.1735033. eCollection 2026.

A new therapeutic approach for Parkinson's disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide

Palmas MF, Aminzadeh K, Runfola M, Parekh P, Porcedda C, Tweedie D, Casula L, Cardia MC, Marongiu J, Etzi M, Lai F, Serra M, Pisanu A, Sogos V, De Simone A, Kim DS, Greig NH, Carta AR.

bioRxiv [Preprint]. 2026 Mar 30:2026.03.26.714051. doi: 10.64898/2026.03.26.714051.

[Basal ganglia and movement disorders : Part 1: the parkinsonian spectrum-Neuroradiological patterns and diagnostic considerations]

Garner M.

Radiologie (Heidelb). 2026 Apr;66(4):285-294. doi: 10.1007/s00117-026-01595-6. Epub 2026 Mar 16.

[Impact of a community-based multisectoral intervention on the health of individuals with parkinson's disease and their family caregivers]

Calzada García M, Ayala A, Navarta Sánchez MV, Palmar Santos AM, Portillo MC, González García B, Carabajal Pendón E, López Manzanares L, Pedraz Marcos A.

Semergen. 2026 Mar;52(2):102694. doi: 10.1016/j.semerg.2026.102694. Epub 2026 Feb 17.

Early impairment of narrative discourse complexity in Parkinson's disease without mild cognitive impairment

García Pérez M, Nieto A, Galtier I.

Arch Clin Neuropsychol. 2026 Feb 27;41(3):acag024. doi: 10.1093/arclin/acag024.

Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study

Nikolcheva T, Pagano G, Anzures-Cabrera J, Trundell D, Kustermann T, Simuni T, Marek K, Pavese N, Seppi K, Stocchi F, Postuma RB, Pross N, Monnet A, Respondek G, Schlegel V, Boak L, Rutten-Jacobs L, Kerchner GA, Brundin P, Svoboda H, Bonni A; PADOVA Investigators; Prasinezumab Study Group.

Lancet. 2026 May 30;407(10544):2227-2240. doi: 10.1016/S0140-6736(26)00865-2.

Impact of a structured quantitative program on [18F]FP-CIT PET interpretation: a multicenter study of diagnostic accuracy, interrater reliability, and reader confidence

Choi B, Ha S, Kang S, Kwon SJ, Son J, Jeong SY, Lee SW, Choe YS, Kim D, Hong CM.

Br J Radiol. 2026 May 1;99(1181):980-988. doi: 10.1093/bjr/tqag045.

Severe immune rejection leading to refractory peri-electrode edema after DBS: a systematic review and one case report

Wang J, Ge M, Gao M, Almasabi F, Zhou G, Wang K, Li K, Xu S, Liu H.

Neurol Sci. 2026 Jan 2;47(1):67. doi: 10.1007/s10072-025-08726-2.

Can virtual reality interventions reduce falls in Parkinson's disease? A systematic review and meta-analysis of randomized trials

Dimitrov G, Maystorska K, Mantarova-Valkova S.

Neurol Sci. 2026 Mar 20;47(4):354. doi: 10.1007/s10072-026-08939-z.

Domain-specific severity profiles in a large Turkish Parkinson's disease cohort using MDS-UPDRS cut-offs

Onder H, Ceylan M, Cokal BG, Yavuz Z, Aktas YE, Aydogan G, Kaya N, Comoglu S.

Parkinsonism Relat Disord. 2026 May;146:108281. doi: 10.1016/j.parkreldis.2026.108281. Epub 2026 Mar 13.

Can transcranial Direct Current Stimulation enhance the efficacy of a rehabilitative intervention for the treatment of Freezing of Gait in Parkinson's disease? A double-blind, randomized controlled study

Madrid J, Batzianouli E, Rutz D, Voisard S, Van den Keybus K, Benninger DH.

J Parkinsons Dis. 2026 Mar;16(2):266-275. doi: 10.1177/1877718X261416181. Epub 2026 Feb 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias